Regent Investment Management LLC Amgen Inc Transaction History

Regent Investment Management LLC

  • $373 Million
  • Q4 2022

A detailed history of Regent Investment Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Regent Investment Management LLC holds 1,193 shares of AMGN stock, worth $372,752. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,193
Previous 1,193 -0.0%
Holding current value
$372,752
Previous $269,000 16.36%
% of portfolio
0.08%
Previous 0.08%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 18, 2022
BUY
$224.46 - $253.15 $7,856 - $8,860
35 Added 3.02%
1,193 $269,000
Q4 2021

Jan 27, 2022
BUY
$198.88 - $227.6 $13,523 - $15,476
68 Added 6.24%
1,158 $261,000
Q2 2021

Jul 16, 2021
SELL
$233.58 - $259.14 $54,891 - $60,897
-235 Reduced 17.74%
1,090 $266,000
Q4 2020

Jan 27, 2021
SELL
$216.38 - $257.67 $21,638 - $25,767
-100 Reduced 7.02%
1,325 $305,000
Q3 2020

Oct 19, 2020
SELL
$234.65 - $260.95 $35,197 - $39,142
-150 Reduced 9.52%
1,425 $362,000
Q2 2020

Jul 29, 2020
SELL
$197.81 - $242.74 $64,288 - $78,890
-325 Reduced 17.11%
1,575 $371,000
Q1 2020

Apr 17, 2020
BUY
$182.24 - $241.7 $18,224 - $24,170
100 Added 5.56%
1,900 $385,000
Q3 2018

Oct 22, 2018
SELL
$185.29 - $208.89 $92,645 - $104,445
-500 Reduced 21.74%
1,800 $373,000
Q2 2018

Jul 16, 2018
SELL
$166.05 - $186.51 $83,025 - $93,255
-500 Reduced 17.86%
2,300 $425,000
Q4 2017

Jan 26, 2018
SELL
$168.79 - $188.59 $75,955 - $84,865
-450 Reduced 13.85%
2,800 $487,000
Q3 2017

Oct 12, 2017
BUY
$167.29 - $191.0 $543,692 - $620,750
3,250
3,250 $606,000

Others Institutions Holding AMGN

# of Institutions
2,930
Shares Held
401M
Call Options Held
6.59M
Put Options Held
6.6M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Regent Investment Management LLC Portfolio

Follow Regent Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email